期刊文献+

两种对比剂对冠脉介入患者肾功能的不同影响 被引量:5

下载PDF
导出
摘要 目的探讨两种对比剂对冠脉介入患者肾功能的不同影响。方法该研究共选择100例行冠脉介入的患者,均为该院2012年9月—2013年9月收治,采用数字表抽取法随机分组,就应用碘海醇(A组,n=50)和碘克沙醇(B组,n=50)对肾功能的不同影响进行分析。结果 A组术后血清Cr浓度明显升高,与B组各时间段比较差异有统计学意义(P<0.05)。A组造影剂肾病率为8%,B组为2%。结论相较碘海醇,碘克沙醇对肾功能的影响相对较轻,等渗造影剂在冠脉介入患者中应用具较高安全性。
作者 文章
出处 《中外医疗》 2014年第22期119-120,共2页 China & Foreign Medical Treatment
  • 相关文献

参考文献10

二级参考文献87

共引文献38

同被引文献44

  • 1MCCULLOUGH P A. Contrast-Induced acute kidney injury [J]. Journal of the American College of Cardiology, 2008,51 (15):1419 -1428.
  • 2BARRETT B J, CARLISLE E J. Meta analysis of the relative nephrotoxicity of high - and low - osmolality iodinated contrastmedia[J]. Radiology, 1993,188(1) : 171- 178.
  • 3HERNANDEZ F, MORA L, GARCIA T J, et al. Comparison of iodixanol and ioversol for the prevention of conintrast-in- duced nephropathy in diabetic patients after coronary angiogra- phy or angioplasty[J]. Revista Espanola de Cardiologia, 2009, 62(12) :1371-1380.
  • 4BOLOGNESE L, FALSINI G, SCHWENKE C A, et al. Im- pact of Iso-Osmolar versus Low Osmolar contrast agents on Contrast-Induced nephropathy and tissue reperfusion in unse- lected patients with ST-Segment elevation myocardial infarc tion undergoing primary percutaneous coronary intervention from the contrast media and nephrotoxicity following primary angioplasty for acute myocardial infarction E CONTRAST- AMI3 trial)[J]. American Journal of Cardiology, 2012, 109 (1):67 -74.
  • 5SHIN D H, CHOI D J, YOUN T J, et al. Comparison of con- trast-induced nephrotoxicity of iodixanol and iopromide in pa- tients with renal insufficiency undergoing coronary angiogra- phy[J]. The American Journal of Cardiology, 2011,108(2): 189-194.
  • 6SH J H, YOUN T J, KOO B K, et al. Renal toxicity evalua tion and comparison between visipaque(iodixanol)and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coro nary angiography: The RECOVER Study: A Randomized Controlled Trial[J]. Journal of the American College of Cardi ology, 2006,48(5) :924- 930.
  • 7RUDNICK M R, DAVIDSON C, LASKEY W, et al. Nephro toxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial [J]. American Heart Journal, 2008,156(4):776- 782.
  • 8LASKEY W, ASPELIN P, DAVIDSON C, et al. Nephroto-xicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mel~itus undergoing coronary an- giographic procedures[J]. American Heart Journal, 2009,158 (5) :822 -828.e3.
  • 9SOLOMON R J, NATARAJAN M K, DOUCET S, et al. Cardiac angiography in rena[ly impaired patients (CARE) study~ a randomized double-blind trial of contrast induced ne phropathy in patients with chronic kidney disease[J].Circula- tion, 2007,115(25) :3189-3196.
  • 10BARRETT B J, KATZBERG R W, THOMSEN H S, et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography~ a double-b|ind comparison of iodixanol and iopamidol[J].Investigative Radi- ology, 2006,41(11) :815-821.

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部